Template:Zika virus: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(17 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Sexually transmitted disease|'''Sexually transmitted diseases Main Page''']]
|-
!
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
Line 46: Line 53:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Clostridium difficile infection classification|Classification]]
[[Zika virus infection classification|Classification]]
|-  
|-  
!
!
Line 95: Line 102:
!
!
[[Zika virus infection laboratory findings|Laboratory Findings]]
[[Zika virus infection laboratory findings|Laboratory Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Zika virus infection evaluation of pregnant women|Evaluation of Pregnant Women]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Zika virus infection evaluation of infants|Evaluation of Infants]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Zika virus infection collection and submission of fetal tissues|Collection and Submission of Fetal Tissues]]
|-  
|-  
!
!
Line 124: Line 149:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Zika virus infection prevention|Prevention]]
[[Zika virus infection prevention|Primary Prevention]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
::[[Zika virus infection guidelines for pregnant women|Guidelines for Pregnant Women]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
::[[Zika virus infection travel notice |Travel Notice]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
::[[Zika virus infection blood donation |Blood Donation]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
!
::[[Zika virus infection sexual transmission |Sexual transmission]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Zika virus secondary prevention |Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Zika virus infection response planning tips|CDC Response Planning Tips]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Zika virus infection risk-based preparedness|Risk-based Preparedness for States]]
|-
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 132: Line 199:
[[Zika virus infection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Zika virus infection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"

Latest revision as of 16:34, 2 March 2017